$1.58 Billion is the total value of Bain Capital Public Equity Management, LLC's 68 reported holdings in Q3 2017. The portfolio turnover from Q2 2017 to Q3 2017 was 270.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AABA | Buy | ALTABA INC | $315,804,000 | +122.4% | 4,767,576 | +82.9% | 19.94% | +133.3% |
| JCI | Buy | JOHNSON CTLS INTL PLC | $85,186,000 | +11.5% | 2,114,329 | +20.0% | 5.38% | +17.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $78,781,000 | +165.9% | 657,876 | +94.1% | 4.97% | +178.9% |
| JACK | Buy | JACK IN THE BOX INC | $67,491,000 | +23.3% | 662,196 | +19.1% | 4.26% | +29.3% |
| NXPI | Buy | NXP SEMICONDUCTORS NV | $64,355,000 | +23.3% | 569,062 | +19.3% | 4.06% | +29.3% |
| CTXS | Buy | CITRIX SYS INC | $60,891,000 | +13.9% | 792,645 | +18.0% | 3.84% | +19.5% |
| NSC | New | NORFOLK SOUTHERN CORP | $51,603,000 | – | 390,224 | +100.0% | 3.26% | – |
| IT | New | GARTNER INC | $40,218,000 | – | 323,269 | +100.0% | 2.54% | – |
| SAN | New | BANCO SANTANDER SAadr | $35,743,000 | – | 5,119,673 | +100.0% | 2.26% | – |
| ORLY | New | O REILLY AUTOMOTIVE INC NEW | $30,104,000 | – | 139,778 | +100.0% | 1.90% | – |
| BEST | New | BEST INCsponsored ads | $26,534,000 | – | 2,216,720 | +100.0% | 1.68% | – |
| AMGN | New | AMGEN INC | $26,468,000 | – | 141,960 | +100.0% | 1.67% | – |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $22,713,000 | – | 244,045 | +100.0% | 1.43% | – |
| KEY | New | KEYCORP NEW | $18,583,000 | – | 987,404 | +100.0% | 1.17% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $17,457,000 | +32.7% | 211,851 | +50.7% | 1.10% | +39.1% |
| CR | New | CRANE CO | $16,116,000 | – | 201,478 | +100.0% | 1.02% | – |
| UMPQ | New | UMPQUA HLDGS CORP | $13,533,000 | – | 693,640 | +100.0% | 0.85% | – |
| IYR | New | ISHARES TRu.s. real es etf | $13,514,000 | – | 169,183 | +100.0% | 0.85% | – |
| IMDZ | Buy | IMMUNE DESIGN CORP | $13,445,000 | +254.1% | 1,299,013 | +233.6% | 0.85% | +270.7% |
| CUDA | Buy | BARRACUDA NETWORKS INC | $11,292,000 | +119.5% | 466,034 | +108.9% | 0.71% | +130.0% |
| AAP | New | ADVANCE AUTO PARTS INC | $10,633,000 | – | 107,187 | +100.0% | 0.67% | – |
| SGEN | New | SEATTLE GENETICS INC | $10,381,000 | – | 190,800 | +100.0% | 0.66% | – |
| HDS | New | HD SUPPLY HLDGS INC | $9,859,000 | – | 273,327 | +100.0% | 0.62% | – |
| AZO | New | AUTOZONE INC | $8,942,000 | – | 15,026 | +100.0% | 0.56% | – |
| MRK | New | MERCK & CO INC | $8,586,000 | – | 134,088 | +100.0% | 0.54% | – |
| JCI | New | JOHNSON CTLS INTL PLCcall | $4,050,000 | – | 20,200 | +100.0% | 0.26% | – |
| SGMO | New | SANGAMO THERAPEUTICS INC | $3,057,000 | – | 203,791 | +100.0% | 0.19% | – |
| JACK | New | JACK IN THE BOX INCcall | $2,388,000 | – | 2,500 | +100.0% | 0.15% | – |
| ALDR | New | ALDER BIOPHARMACEUTICALS INC | $2,279,000 | – | 186,040 | +100.0% | 0.14% | – |
| GE | New | GENERAL ELECTRIC COput | $1,924,000 | – | 25,000 | +100.0% | 0.12% | – |
| GE | New | GENERAL ELECTRIC COcall | $1,662,000 | – | 45,535 | +100.0% | 0.10% | – |
| DYN | New | DYNEGY INC NEW DEL | $1,356,000 | – | 138,537 | +100.0% | 0.09% | – |
| NKTR | New | NEKTAR THERAPEUTICScall | $1,155,000 | – | 3,000 | +100.0% | 0.07% | – |
| CRIS | New | CURIS INC | $1,016,000 | – | 682,125 | +100.0% | 0.06% | – |
| PTI | Buy | PROTEOSTASIS THERAPEUTICS IN | $774,000 | -37.2% | 368,590 | +39.9% | 0.05% | -33.8% |
| FB | New | FACEBOOK INCput | $385,000 | – | 667 | +100.0% | 0.02% | – |
| LLY | New | LILLY ELI & COput | $49,000 | – | 2,000 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Brookside Capital Investors, L.P. #1
- Brookside Capital Partners Fund, L.P. #2
- Brookside Capital Investors II, L.P. #3
- Brookside Capital Trading Fund, L.P. #4
- Brookside Capital Investors III, L.P. #5
- Brookside Capital Partners Fund III, L.P. #6
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CITRIX SYS INC | 18 | Q3 2018 | 6.7% |
| QUINTILES TRANSNATIO HLDGS I | 18 | Q3 2017 | 3.5% |
| AFFIMED N V | 16 | Q1 2019 | 1.0% |
| BALL CORP | 13 | Q1 2019 | 7.2% |
| RADIUS HEALTH INC | 13 | Q2 2017 | 8.4% |
| TRANSDIGM GROUP INC | 11 | Q2 2016 | 10.1% |
| ULTA SALON COSMETCS & FRAG I | 11 | Q4 2015 | 5.4% |
| VIASAT INC | 11 | Q2 2017 | 7.5% |
| AETNA INC NEW | 11 | Q2 2017 | 4.1% |
| GODADDY INC | 10 | Q1 2019 | 5.7% |
View Bain Capital Public Equity Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Affimed N.V. | February 14, 2019 | 2,362,813 | 3.8% |
| IMMUNE DESIGN CORP. | February 14, 2019 | 892,061 | 1.8% |
| REVA Medical, Inc. | February 14, 2019 | 296,502,220 | 7.2% |
| MULESOFT, INC | February 14, 2018 | 1,404,025 | 1.9% |
| CONCERT PHARMACEUTICALS, INC. | February 28, 2014 | 1,147,833 | 6.7% |
| IDENIX PHARMACEUTICALS INC | February 12, 2014 | 13,115,858 | 9.8% |
| NORTHSTAR REALTY FINANCE CORP. | February 12, 2014 | 7,657,781 | 2.6% |
| PORTOLA PHARMACEUTICALS INC | February 12, 2014 | 400,000 | 1.0% |
| Dicerna Pharmaceuticals Inc | February 10, 2014 | 1,337,000 | 8.0% |
| RingCentral Inc | February 07, 2014 | 471,073 | 5.5% |
View Bain Capital Public Equity Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2020-11-16 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-15 |
| 13F-HR | 2020-02-14 |
| 13F-HR | 2019-11-14 |
| 13F-HR | 2019-08-14 |
| 13F-HR | 2019-05-15 |
| 13F-HR | 2019-02-14 |
| SC 13G/A | 2019-02-14 |
| SC 13G/A | 2019-02-14 |
View Bain Capital Public Equity Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.